Everything-But-CRM Growth Drivers Slow In Q2 For St. Jude
This article was originally published in The Gray Sheet
Executive Summary
Amid a persistently contracting cardiac rhythm management market, the firm’s CRM business, while not growing, performed better than expected in the second quarter. But several of it its non-CRM businesses, which the company relies on to drive growth, experienced a slowdown.
You may also be interested in...
St. Jude Confident In 2013 Growth Plan Despite Market Challenges
Anticipated growth drivers include the firm’s MediGuide catheter tracking system, EnligHTN multi-electrode renal denervation system and Portico transcatheter aortic valve, aided by a return to stability of the cardiac rhythm management market by the first half of 2013.
Medical Device Market & Industry Briefs, August 2012
Brief summaries of recent medtech market and industry developments. This month we cover continuing pressures on the DES and ICD markets, update Edwards’ efforts to roll out its Sapien device for TAVR, and report on QLT’s decision to sell its punctal plug technology.
St. Jude Medical Tags Device Tax As Acquisition Opportunity-Maker
The company is maintaining reserves so it can move forward with beneficial acquisition opportunities as they arise, opportunities that St. Jude executives think might become more frequent next year with the 2.3% device tax in place.